Literature DB >> 33479613

Introducing a new category of activity cliffs combining different compound similarity criteria.

Huabin Hu1, Jürgen Bajorath1.   

Abstract

Activity cliffs (ACs) are pairs of structurally similar or analogous active compounds with large differences in potency against the same target. For identifying and analyzing ACs, similarity and potency difference criteria must be determined and consistently applied. This can be done in various ways, leading to different types of ACs. In this work, we introduce a new category of ACs by combining different similarity criteria, including the formation of matched molecular pairs and structural isomer relationships. A systematic computational search identified such ACs in compounds with activity against a variety of targets. In addition to other ACs exclusively formed by structural isomers, the newly introduced category of ACs is rich in structure-activity relationship (SAR) information, straightforward to interpret from a chemical perspective, and further extends the current spectrum of ACs. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479613      PMCID: PMC7484988          DOI: 10.1039/c9md00463g

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  15 in total

1.  MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.

Authors:  Xiaoying Hu; Ye Hu; Martin Vogt; Dagmar Stumpfe; Jürgen Bajorath
Journal:  J Chem Inf Model       Date:  2012-04-17       Impact factor: 4.956

2.  Monitoring global growth of activity cliff information over time and assessing activity cliff frequencies and distributions.

Authors:  Dagmar Stumpfe; Jürgen Bajorath
Journal:  Future Med Chem       Date:  2015-08-27       Impact factor: 3.808

3.  Recent progress in understanding activity cliffs and their utility in medicinal chemistry.

Authors:  Dagmar Stumpfe; Ye Hu; Dilyana Dimova; Jürgen Bajorath
Journal:  J Med Chem       Date:  2013-09-13       Impact factor: 7.446

4.  Molecular similarity in medicinal chemistry.

Authors:  Gerald Maggiora; Martin Vogt; Dagmar Stumpfe; Jürgen Bajorath
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

5.  Second-generation activity cliffs identified on the basis of target set-dependent potency difference criteria.

Authors:  Huabin Hu; Dagmar Stumpfe; Jürgen Bajorath
Journal:  Future Med Chem       Date:  2019-03-19       Impact factor: 3.808

6.  Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles.

Authors:  Dagmar Stumpfe; Dilyana Dimova; Jürgen Bajorath
Journal:  J Med Chem       Date:  2016-08-08       Impact factor: 7.446

7.  Chiral Cliffs: Investigating the Influence of Chirality on Binding Affinity.

Authors:  Nadine Schneider; Richard A Lewis; Nikolas Fechner; Peter Ertl
Journal:  ChemMedChem       Date:  2018-06-11       Impact factor: 3.466

8.  Introducing a new category of activity cliffs with chemical modifications at multiple sites and rationalizing contributions of individual substitutions.

Authors:  Dagmar Stumpfe; Huabin Hu; Jürgen Bajorath
Journal:  Bioorg Med Chem       Date:  2019-06-28       Impact factor: 3.641

9.  Advancing the activity cliff concept.

Authors:  Ye Hu; Dagmar Stumpfe; Jürgen Bajorath
Journal:  F1000Res       Date:  2013-09-30

10.  The ChEMBL database in 2017.

Authors:  Anna Gaulton; Anne Hersey; Michał Nowotka; A Patrícia Bento; Jon Chambers; David Mendez; Prudence Mutowo; Francis Atkinson; Louisa J Bellis; Elena Cibrián-Uhalte; Mark Davies; Nathan Dedman; Anneli Karlsson; María Paula Magariños; John P Overington; George Papadatos; Ines Smit; Andrew R Leach
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

View more
  2 in total

1.  Implications of Additivity and Nonadditivity for Machine Learning and Deep Learning Models in Drug Design.

Authors:  Karolina Kwapien; Eva Nittinger; Jiazhen He; Christian Margreitter; Alexey Voronov; Christian Tyrchan
Journal:  ACS Omega       Date:  2022-07-19

2.  Nonadditivity in public and inhouse data: implications for drug design.

Authors:  D Gogishvili; E Nittinger; C Margreitter; C Tyrchan
Journal:  J Cheminform       Date:  2021-07-02       Impact factor: 5.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.